Class Attys In Vioxx Case Ask For Approval Of $1B Deal
Co-lead counsel for Merck & Co. Inc. shareholders that reached a $1.06 billion deal with the pharmaceutical giant to resolve multidistrict litigation over the alleged illegal marketing of the drug Vioxx...To view the full article, register now.
Already a subscriber? Click here to view full article